Feng Wang, PhDAssociate Director and Principal Investigator, Institute of Biophysics at Chinese Academy of Sciences
Feng Wang, PhD, is the associate director and principal investigator at Key Laboratory of Protein and Peptide Therapeutics of Institute of Biophysics, Chinese Academy of Sciences. His research work focuses on developing new methods to identify and design novel antibody and antibody derivatives as therapeutics. Before joining IBP, Dr. Wang worked with Dr. Peter Schultz to establish California Institute for Biomedical Research (CaliBR) in 2012. He was principal investigator in charge of the group of protein therapeutics from 2012 to 2017. His work is currently supported by multiple state funding agencies and was funded by Bill & Melinda Gates Foundation, Juvenile Diabetes Research Foundation (JDRF), Pfizer and Merck & CO.
Dr. Wang got his Ph.D in biochemistry at TAMU in 2007 and did his postdoc research work at The Scripps Research Institute, La Jolla, California.